Related Experiment Video

Updated: Sep 28, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Various reasons for repeat dilatation of stented pulmonary arteries in paediatric patients

M B E Schneider1, P Zartner, K Duveneck

  • 1Department of Paediatric Cardiology, Charité Medical Centre, Humboldt University, Berlin, Germany. martin.schneider@charite.de

Heart (British Cardiac Society)
|October 17, 2002
PubMed

Insights

Repeat balloon angioplasty for pulmonary artery stenosis is often needed to accommodate patient growth. Other reasons include intimal proliferation and external compression, particularly in pediatric patients.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Pulmonary artery stenosis (PAS) is a significant challenge in pediatric cardiology.
  • Balloon-expandable stents are used to treat PAS, but repeat interventions are sometimes necessary.

Purpose of the Study:

  • To investigate the reasons for repeat interventions in patients with pulmonary artery stenosis treated with balloon-expandable stents.
  • To analyze the time intervals between repeat interventions.

Main Methods:

  • Retrospective observational study at a single pediatric cardiology center.
  • Analysis of 38 patients (mean age 6.9 years) who underwent 46 stent implantations for pulmonary artery stenosis.
  • Follow-up focused on stent adaptation to growth, pulmonary artery development, and right ventricle pressure gradients.

Main Results:

  • 56 stents were implanted in 46 lesions.
  • During a mean follow-up of 2.2 years, 40 repeat dilatations were performed on 28 stents.
  • The mean time between stent implantation and repeat dilatation was 15.5 months.

Conclusions:

  • Repeat dilatation is primarily performed to adjust stent diameter for patient growth.
  • Other indications for repeat intervention include intimal proliferation (17.5%) and external compression (25%).
  • Reasons for repeat interventions differ between pediatric and adult patients, with pediatric cases requiring interventions for diverse reasons.
Abstract

More Related Videos

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position11:20

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position

Published on: April 1, 2022

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...